Evidence map›Paper›PMID 30713336›Full record

ArticleMedical science monitor basic research2019

Autophagy and Oncosis/Necroptosis Are Enhanced in Cardiomyocytes from Heart Failure Patients.

Giovanni Corsetti, Carol Chen-Scarabelli, Claudia Romano, Evasio Pasini, Francesco S Dioguardi, Francesco Onorati, Richard Knight, Hemang Patel, Louis Saravolatz, Giuseppe Faggian and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Medical science monitor basic research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 51 citations in OpenAlex.

  1. Review
  2. Review
  3. One Syndrome, Many Faces: A Unified Perspective on Heart Failure Phenotypes.International journal of molecular sciences · 2025
    Review
  4. Article
  5. A Need to Preserve Ejection Fraction during Heart Failure.International journal of molecular sciences · 2024
    Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 3 countries.

Giovanni CorsettiDivision of Human Anatomy and Physiopathology, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Carol Chen-ScarabelliCenter for Heart and Vessel Preclinical Studies, Department of Internal Medicine, St. John Hospital and Medical Center, Wayne State University, Detroit, MI, USA.
Claudia RomanoDepartment of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Evasio PasiniScientific Clinical Institutes Maugeri, Cardiac Rehabilitation Lumezzane Institute, Brescia, Italy.
Francesco S DioguardiDepartment of Internal Medicine, University of Cagliari, Cagliari, Italy.
Francesco OnoratiDivision of Cardiovascular Surgery, Verona University Hospital, Verona, Italy.
Richard KnightMedical Research Council (MRC) Toxicology Unit, University of Cambridge, Cambridge, United Kingdom.
Hemang PatelGeneral Medical Education, Department of Internal Medicine, Ascension St. John Hospital, Detroit, MI, USA.
Louis SaravolatzDepartment of Medicine, Ascension St John Hospital and Wayne State University School of Medicine, Detroit, MI, USA.
Giuseppe FaggianDivision of Cardiovascular Surgery, Verona University Hospital, Verona, Italy.
Tiziano M ScarabelliCenter for Heart and Vessel Preclinical Studies, Department of Internal Medicine, St. John Hospital and Medical Center, Wayne State University, Detroit, MI, USA.
St. John Hospital & Medical Center · USUniversity of Brescia · ITUniversity of Verona · ITIstituti Clinici Scientifici Maugeri · ITMedical Research Council · GBUniversity of Cagliari · ITWayne State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Although originally described as a survival mechanism, it is unknown whether and to what extent autophagy is implicated in the terminal stages of heart failure. Here, we studied magnitude and evolution of autophagy in patients with intractable heart failure. MATERIAL AND METHODS Myocardial samples were obtained from 22 patients with ischemic cardiomyopathy and idiopathic dilated cardiomyopathy who were undergoing cardiac transplantation. Hearts from 11 patients who died from non-cardiac causes were used as control samples. Autophagy was evaluated by immunostaining with a monoclonal microtubule associated protein light chain 3 (LC3)-II antibody, while the relationship of autophagy with apoptosis and oncosis was assessed by double staining with TUNEL (terminal deoxynucleotidyl transferase - mediated deoxyuridine triphosphate nick end labeling) assay and complement 9 (C9) immunological staining, respectively. In addition, several necroptotic markers, including RIP1 and RIP3 (receptor interacting protein kinase 1 and 3), anti-C3 (cleaved-caspase-3), and anti-NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) were assessed by immunohistochemistry. RESULTS Anti-LC3-II staining was detected in 8.7±1.6% of the heart failure patient heart samples and in 1.2±0.3% of control patient heart samples. Vacuole formation started at one nuclear pole, before becoming bipolar and involving the cytosol. Subsequently, the autophagic process extended also to the nuclei, which underwent a progressive vacuolization and disintegration, assuming a peculiar "strawberry like appearance". Myocytes with extensive vacuole formation exhibited nuclear degeneration, which was associated with TUNEL, C3, C9, RIP1, and RIP3 positive staining. Conversely, myocytes with less extensive vacuole formation showed RIP1 and NF-κB positive staining, though not positivity for other cell death markers. CONCLUSIONS Autophagy was extensively detected in end-stage heart failure and its progression, resulted in secondary cell death, with occurrence of oncosis and necroptosis exceeding that of apoptosis. Conversely, activation of the RIP1/NF-κB pathway was associated with cell survival.

Indexed as

ApoptosisAutophagyCaspase 3Heart FailureHumansMaleMiddle AgedMyocytes, CardiacNecrosisNF-kappa BNuclear Pore Complex ProteinsRNA-Binding ProteinsSignal TransductionAGFG1 protein, humanCASP3 protein, humanCaspase 3NF-kappa BNuclear Pore Complex ProteinsRNA-Binding Proteins

Identifiers

PMID30713336
PMCPMC6373236
OpenAlexW2914732328

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.